MedTrace Logo

Clinical Evaluation of the Ethmoid Sinus Spacer

NCT01054703 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-08-06

Study results available
· View outcomes & findings →

Summary

Evaluation of treatment of the ethmoid sinuses with the Ethmoid Sinus Spacer and Access system

Conditions

  • Sinusitis, Chronic Rhinosinusitis

Interventions

DEVICE

Ethmoid Sinus Spacer

Ethmoid Sinus Spacer and Access System used for the local delivery of Kenalog-40

Sponsors & Collaborators

  • Acclarent

    collaborator INDUSTRY

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Fred Kuhn, MD · Georgia Nasal and Sinus Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-01
Primary Completion
2007-11-01
Completion
2007-11-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01054703 on ClinicalTrials.gov